Connect with us

Hi, what are you looking for?


US FDA Approves First COVID-19 Treatment For Young Children

COVID-19 treatment

LOS ANGELES, April 26 (Bernama) — The US Food and Drug Administration (FDA) on Monday expanded its approval of the COVID-19 treatment Veklury, also known as remdesivir, to include pediatric patients 28 days of age and older weighing at least 3 kilogrammes who are infected by SARS-CoV-2.

This action makes Veklury the first approved COVID-19 treatment for children less than 12 years of age, said the FDA.

Veklury is approved for young children who are hospitalised, or have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, according to the FDA, said Xinhua.

Previously Veklury was only approved to treat COVID-19 for certain adults and pediatric patients 12 years of age and older who weigh at least 40 kg.

“As COVID-19 can cause severe illness in children, some of whom do not currently have a vaccination option, there continues to be a need for safe and effective COVID-19 treatment options for this population,” said Patrizia Cavazzoni, director of the FDA’s Centre for Drug Evaluation and Research.

Sources: BERNAMA

You May Also Like


ANKARA, May 11 (Bernama) — Bill Gates, co-chair of the Bill & Melinda Gates Foundation, announced Tuesday that he has tested positive for COVID-19....


SEOUL, May 6 (Bernama) — Asia’s top sports body announced Friday the 19th Asian Games, scheduled to take place in the Chinese city of...


KUALA LUMPUR (Bernama) – The COVID-19 situation in the country is under control after a week’s transition to endemic phase and despite the emergence...


SEOUL, April 6 (Bernama) — The South Korean Cabinet on Wednesday approved 36 billion won (US$29.5 million) in reserve government funds for President-elect Yoon...

Copyright © 2021 Siakap Keli Sdn. Bhd.